The 11th European Biosimilars Congress, will take place during April 26-27, 2018 at Rome, Italy. 

The 11th European Biosimilars Congress

April 26-27, 2018 Rome, Italy


The 11th European Biosimilars Congress, will take place during April 26-27, 2018 at Rome, Italy. The theme of the congress is 'The Developmental Strategies and Uptake of Biosimilars through a Decade in Europe ' and its purpose is to bring together Professors, scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials, CROs and students from around the world. The passage of biosimilars through a decade at Europe finds much requirement for discussion also focussing the latest developments in the field of biologics and biosimilars.

Previous Speakers


Euro Biosimilars 2018 Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. The ‘Best Poster Award’ is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase.

Sessions

  • Current Challenges in Developing Biosimilars
  • Emerging Biosimilars in Therapeutics
  • Analytical Strategies for Biosimilars
  • Regulatory Approach of Biosimilars
  • Biosimilar Companies and Market Analysis
  • Innovative Approach for Biosimilars
  • Clinical Development of Biosimilars
  • Consequences of Brexit on Biosimilars
  • Intellectual Property Rights
  • Globalization of Biosimilars
  • Bioequivalence Assessment
  • Biosimilars Research Pipeline
  • BCS and IVIVC Based Biowaivers
  • Biosimilar Market and Cost Analysis,
  • Challenges in Biosimilars Pharmacovigilance
  • Legal Issues and BPCI Act
  • Entrepreneurs Investment Meet

The 11th European Biosimilars Congress

Why attend?

Conduct demonstrations, distribute information, meet with current and potential Scientists to update yourself with latest technological advancememts and new research, and receive name recognition at this 3-days' event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in the era of follow-on-biologics and biosimilars are hallmarks of this conference.

The Euro Biosimilars conference 2018 is owned to bring together the worldwide top pharmaceuticals, biotechnology and regulatory representatives under one roof that will provide them the best platform to update and share knowledge related to biosimilars and biologics. Hence, the International Biosimilar Conference will unfold the multiple facets of biosimilars, ranging from the evolving regulatory landscapes, biosimilar guidelines to the legal and economic aspects and the then current challenges in biosimilar development.

Target Audience

  • Directors, CEO’s of Organizations
  • Business Development Managers
  • Chief Scientific Officers
  • R&D Researchers from Biosimilar and Bioslogics Industries
  • Professors, Associate Professors, Assistant Professors
  • PhD Scholars
  • Patent Attorneys
  • Intellectual Property Attorneys
  • Investment Analysts
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneurs


If you want to know more about the 11th European Biosimilars Congress or if you want to register for the conference, please contact us!